ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1236

Peripheral-Blood B-Cell Subset Disturbances in Whipple’s Disease

Maelle Le Goff1, Divi Cornec2, Dewi Guellec1, Thierry Marhadour1, Valérie Devauchelle-Pensec1, Sandrine Jousse-Joulin1, Marion Herbette1, Jean-Michel Cauvin3, Clara Le Guillou3, Yves Renaudineau4, Jacques-Olivier Pers5 and Alain Saraux1, 1Rheumatology, CHU Brest, Brest, France, 2Rheumatology and UMR1227, Lymphocytes B et Autoimmunité, CHU Brest, Brest, France, 3CDC, CHU Brest, Brest, France, 4U1227, Université de Brest, inserm, Labex IGO, CHU de brest, Brest, France, 5U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, diagnosis, immunology, infection and lymphocytes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Whipple’s disease (WD) is a rare, systemic, disease caused by the intracellular Gram-positive bacterium Tropheryma whipplei (TW). This ubiquitous commensal organism is transmitted among humans via the oro-fecal route. Chronic WD and the immune system are closely linked. To our knowledge, no studies have evaluated the potential role for B cells in WD. We noticed lymphocyte subset abnormalities similar to those seen in primary Sjögren’s syndrome in patients whose symptoms suggested ankylosing spondyloarthritis (inflammatory low back pain) or rheumatoid arthritis (chronic polyarthritis). We then observed the same abnormalities in patients with infectious rheumatic diseases due in particular to bartonella (cat-scratch disease) or TW. We therefore designed the present study with the aim of describing peripheral-blood lymphocyte subsets, with special attention to B cells, in patients with WD. We aimed to assess whether any abnormalities found were sufficiently characteristic to help in diagnosing and monitoring WD.

Methods:

Consecutive patients seen between 2010 and 2016 for suspected inflammatory joint disease were identified retrospectively. Results of standardized immunological and serological tests and of peripheral-blood B-cell and T-cell subset analysis by flow cytometry were collected. Patients with criteria suggesting WD underwent PCR testing for Tropheryma whipplei, and those with diagnosis of WD (cases) were compared to those without diagnosis (controls). We used ROC curve analysis to evaluate the diagnostic value of flow cytometry findings for WD.

Results:

Among 2917 patients seen for suspected inflammatory joint disease, 121 had suspected WD, including 9 (9/121, 7.4%) with a positive PCR and a dramatic response to antibiotic therapy for WD. Proportions of T cells and NK cells were similar between cases and controls, whereas cases had a lower proportion of circulating memory B cells (IgD–CD38low, 18.0%±9.7% vs. 26.0%±14.2%, P=0.041) and higher ratio of activated B cells over memory B cells (4.4±2.0 vs. 2.9±2.2, P=0.023). Among peripheral-blood B-cells, the proportion of IgD+CD27- naive B cells was higher (66.2%±18.2% vs. 54.6%±18.4%, P=0.047) and that of IgD-CD27+ switched memory B cells lower (13.3%±5.7% vs. 21.4%±11.9%, P=0.023), in cases vs. controls. The criterion with the best diagnostic performance was a proportion of IgD+CD27- naive B cells above 70.5 %, which had 73% sensitivity and 80% specificity.

Conclusion:

Our study provides data on peripheral-blood B-cell disturbances that may have implications for the diagnosis and pathogenetic understanding of WD.


Disclosure: M. Le Goff, None; D. Cornec, None; D. Guellec, None; T. Marhadour, None; V. Devauchelle-Pensec, None; S. Jousse-Joulin, None; M. Herbette, None; J. M. Cauvin, None; C. Le Guillou, None; Y. Renaudineau, EFPIA, 2; J. O. Pers, None; A. Saraux, None.

To cite this abstract in AMA style:

Le Goff M, Cornec D, Guellec D, Marhadour T, Devauchelle-Pensec V, Jousse-Joulin S, Herbette M, Cauvin JM, Le Guillou C, Renaudineau Y, Pers JO, Saraux A. Peripheral-Blood B-Cell Subset Disturbances in Whipple’s Disease [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/peripheral-blood-b-cell-subset-disturbances-in-whipples-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/peripheral-blood-b-cell-subset-disturbances-in-whipples-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology